XML 25 R23.htm IDEA: XBRL DOCUMENT v3.20.1

Segment Reporting (Tables)

3 Months Ended

Feb. 29, 2020

Segment Reporting [Abstract]

Summary of Net Revenue, Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense, Income Tax Benefit (Expense), Other Comprehensive Income, and Assets by Segment

The following table shows, by segment: net revenue, cost of sales, depreciation and amortization, operating profit, interest expense, and income tax (expense) benefit for the three months ended February 29, 2020 and February 28, 2019:

		For the three months ended February 29, 2020				For the three months ended February 28, 2019
Net revenue
Umbilical cord blood and cord tissue stem cell service		$	7,406,288			$	7,335,027
PrepaCyte®-CB			60,407				25,720
Public cord blood banking			154,079				134,365
Total net revenue		$	7,620,774			$	7,495,112
Cost of sales
Umbilical cord blood and cord tissue stem cell service		$	2,055,075			$	2,038,616
PrepaCyte®-CB			41,117				160,006
Public cord blood banking			406,952				267,605
Total cost of sales		$	2,503,144			$	2,466,227
Depreciation and amortization
Umbilical cord blood and cord tissue stem cell service		$	37,327			$	47,917
PrepaCyte®-CB			6,894				9,063
Public cord blood banking			—				—
Total depreciation and amortization		$	44,221			$	56,980
Operating income
Umbilical cord blood and cord tissue stem cell service		$	1,489,548			$	1,130,251
PrepaCyte®-CB			12,396				(143,349	)
Public cord blood banking			(252,874	)			(133,240	)
Total operating income		$	1,249,070			$	853,662
Interest expense
Umbilical cord blood and cord tissue stem cell service		$	365,299			$	406,925
PrepaCyte®-CB			—				—
Public cord blood banking			—				—
Total interest expense		$	365,299			$	406,925
Income tax expense
Umbilical cord blood and cord tissue stem cell service		$	252,380			$	104,667
PrepaCyte®-CB			—				—
Public cord blood banking			—				—
Total income tax expense		$	252,380			$	104,667

The following table shows the assets by segment as of February 29, 2020 and November 30, 2019:

		As of February 29, 2020				As of November 30, 2019
Assets
Umbilical cord blood and cord tissue stem cell service		$	31,001,108			$	28,975,002
PrepaCyte®-CB			270,095				289,804
Public cord blood banking			13,459,243				13,621,354
Total assets		$	44,730,446			$	42,886,160

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration